Clinical trial outcomes can help inform our understanding of cancer and improve prevention, diagnosis, treatment, and care. But this progress could not happen without the people who choose to participate in and those who connect people with trials.
As a participant in a longitudinal study about her rare condition, Alyssa has been coming to the NIH every year since she was in elementary school. Researchers have given her and her family updates and guidance about her growth and have gained valuable data about the way the syndrome is expressed as a person ages.
Annette’s daughter, Lauren, received treatment at NIH for Ewing’s sarcoma, a type of cancer. She shares how her experience at the NIH led her to begin painting hospital windows in the NIH Clinical Center.
Caitlin tells about her experience living with multiple sclerosis and her decision to be a part of clinical trial for MS at the National Institutes of Health. The trial has just ended and Caitlin reflects on her fears of deteriorating quickly without treatment and her hopes that her participation will help lead to a treatment or cure one day for others with MS.
Chuck Rose, creative director at NCI, shares his story about living with metastatic prostate cancer. In addition to emotional and physical effects stemming from their diagnosis and treatment, many survivors experience a new vulnerability as they look ahead.
To truly understand someone’s experience, put yourself in their shoes. No doubt, you have heard this adage and it is certainly the case for the many people who participate in clinical research. Many of us who work at NIH regularly say how invaluable clinical study participants are to improving public health, but have you tried on their shoes yet?
Dewayne has a strong family history of Alzheimer's disease and he's always known that it could be in his future. So, he decided to volunteer for a study at UT Southwestern's Alzheimer's Disease Center where he could contribute to research efforts and be monitored for signs of cognitive impairment. His decision to volunteer changed his life and set him on a new course.
Dhruv always seemed to have skin infections, and he got sick easily. Doctors in his native India originally believed his skin infections were a type of allergy. But medication wasn’t helping. Bloodwork eventually showed Dhruv had been born with a compromised immune system.
Emily Whitehead had just celebrated her 5th birthday in 2010 when she was diagnosed with acute lymphoblastic leukemia (ALL). More than 90% of children diagnosed with ALL are cured, but Emily relapsed twice.
On the surface, Holden looks like the typical ten-year-old boy — soccer jersey, blonde hair and blue eyes, even freckles. But spend some time with him and you will realize that he is dealing with a chronic illness, Crohn’s disease, that makes his life anything but ordinary.
Jamie Gentille was born with a cardiac defect called tetralogy of Fallot, which required surgery when she was 3 years old. During that surgery, Jamie received a blood transfusion that was infected with HIV. Hear Jamie tell her story about participating in clinical research.
Before me, there were hundreds and thousands of other people with Parkinson's who participated in clinical trials that gave me the ability to have the medications that I take today. If people today do not participate in clinical trials, there will be no cure. There will be no new medications.
I participated in an NIH-funded clinical trial in high school because my mom has type 1 diabetes. Although I decided to participate to help the scientists learn more about my mom's condition, it ended up having a big benefit for me as well.
Nineteen-year-old Joel Rodriguez didn’t think he would be able to eat again. However, a collaboration between surgeons in the Center for Cancer Research (CCR) and the National Institute of Allergy and Infectious Diseases (NIAID) gave that back to him.
NINDS Clinical Director Dr. Avindra Nath meets with clinical trial participant Mr. John Michael. Dr. Nath and his research team are conducting an NIH study to better understand amyotrophic lateral sclerosis or ALS. In the video, Mr. Michael shares his experience as a trial participant while Dr. Nath discusses his research.
Juliana was born with sickle cell anemia, a condition in which the body’s red blood cells are sickle-shaped. It slows or blocks blood flow to parts of the body, causing intense pain called "crisis." Hear Juliana tell her story about how participating in a clinical trial saved her life.
Several years past his WWII military service at Pearl Harbor, following a routine visit to the doctor, Leonard Gardner once again faced imminent mortality—but he didn’t know it until many months later.
Participating in this clinical trial gave me some insights into how quality clinical research is done. Both the doctor and nurses answered any questions I had about the overall study and what they were finding, making me feel part of a larger effort to help women who experience severe difficulties with this phase of life.
As a side effect of a past surgery, Lydia developed hypoparathyroidism, a disorder that inhibits her body’s ability to manufacture enough of a particular hormone. Through a clinical study, Lydia works with researchers to manage the condition’s effects on her bones, and scientists gain useful information about the effects of using a synthetic replacement version of the hormone she lacks.
While COVID-19 surged in the United States in 2020, a colonoscopy revealed that Marilyn had stage III colon cancer. “I had no symptoms of colon cancer, so I was surprised to hear I had it,” Marilyn said. She’s glad she listened to her doctor and had the cancer screening test.
I had a sister who died of cancer, so I believe it is very important for healthy people to help. We have a role to play in helping find new, more effective treatments that can save lives. What could be better than that?
Nicholas was diagnosed with sickle cell disease soon after he was born. He suffered from hand-feet syndrome as a baby ("He cried and scooted around a lot because of pain in his hands and feet," recalls his mother, Bridget) and had his gallbladder and spleen taken out at age 5.
Olivia was diagnosed with stage-4 non-Hodgkin’s lymphoma when she was just 15 years old. It was a rare diagnosis for a teenager, and she was treated in an adult ward. Now almost 50, she returned to the NIH, where Harrison, her husband of 25 years now works, to reflect on how facing her mortality at a young age has affected her life since.
The clinical trial helps so much because one of the drugs I'm using now I used in the clinical trial, so if it helps other people, and everybody there on the days I go has the same disease usually, then I'm happy for that.
In January 2016, Sarah Rosenfeld had such severe pain shooting down her legs she couldn’t walk, sleep or care for her young daughters. After weeks of physical therapy for what she thought was sciatica, she had an MRI. Thirty-seven-year-old Rosenfeld learned she had something far worse: myxopapillary ependymoma, a rare cancerous tumor in her spinal cord.
Two years after Shirley’s mother passed away from systemic lupus erythematosis (SLE), Shirley was diagnosed with SLE. She shares her story of her diagnosis and subsequent treatment at the National Institutes of Health (NIH).
In a series of Twitter posts, NCI’s Center for Cancer Research (CCR) shares the story of Samantha Seinfeld, a metastatic breast cancer survivor who participated in a CCR first-in-human clinical trial over 10 years ago. Since then, she has remained cancer-free.
I was born and raised in Culiacan, Mexico, the third of four siblings. I grew up in a very matriarchal family. I contracted hepatitis A when I was 7 years old, and though I made it through, I considered it a curse. I could not donate blood, and that always made me unhappy.
Sue Scott was diagnosed with stage 1B2 cervical cancer in 2011. She went through the standard course of prescribed treatment, which works for 65% of people with cervical cancer. Unfortunately, she was part of the 35% for whom it did not work. Hear Sue tell her story about how participating in a clinical trial saved her life.
Niemann-Pick disease type C, or NPC, is a rare childhood disease that gradually impairs brain function and movement. Researchers at the National Institutes of Health conduct NPC research, including clinical trials that test promising therapies.
Warner decided to volunteer for the Alzheimer's Disease Neuroimaging Initiative (ADNI) clinical trial for two reasons: his trust in the physician running the trial and a family history of the disease. He relates his personal experience participating in a trial, describing the various tests he takes and the benefits he perceives for his own health.
I had never knowingly encountered anyone who was HIV positive until I was a sophomore in high school. It was then that I learned that my uncle had contracted the virus and his health was rapidly failing. I was really surprised that my family never talked about his HIV or how he may have contracted the virus.
Dr. Madhav Thambisetty of the National Institute on Aging at NIH discusses the role of study partners in Alzheimer's disease clinical trials. A study partner relates her experience in an Alzheimer's trial.
The purpose of clinical research is to help understand how the human body works and how health and disease come about. Why is it important for all women to consider participating in clinical trials? The NIH Office of Research on Women’s Health (ORWH) answers this question by sharing personal experiences from clinical trial participants and insights from NIH leaders.
National Cancer Institute Center for Cancer Research scientist and physician, Lauren V. Wood, M.D., discusses immunotherapy and cancer. Immunotherapy is a type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.
Dr. James Gulley, Director of CCR's Clinical Immunotherapy Group, takes you into his clinic where he plans and conducts numerous clinical trials using cancer vaccines to treat and prevent cancer. You will hear from three of Dr. Gulley's patients currently enrolled in his clinical trials.
In this video, more than a dozen pediatric clinician-researchers, doctors, and nurses talk about the importance of conducting clinical trials for children and what motivates them to do this critical work.
Carl Lejuez, Professor of Clinical Psychology at the University of Maryland, College Park, and Director of the Center for Addictions, Personality & Emotional Research, discusses translational research — studying the basic internal processes that lead people to addictive behaviors.
Charlene Quinn, Associate Professor, University of Maryland School of Medicine, discusses new mobile technologies and behavioral changes that could reduce the number of diabetes cases related to lifestyle and eating habits.
The National Database for Autism Research provides a way for scientists share data on human autism studies. Families with autism can accelerate discoveries by participating in research and consenting to have their data shared.
Dr. Neal Young talks about the importance of conducting and participating in clinical trials and the difference these studies have made in the lives of people with severe blood and bone marrow diseases such as aplastic anemia.
Clinical research has shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children.
NIH-supported ResearchMatch.org helps volunteers and researchers connect for clinical trials. Researchers and clinical trial participants explain what it's like to volunteer for a trial and how it promotes medical advances.
In a 2010 movie, The King’s Speech, many learned for the first time about King George VI of England’s speech challenge known as stuttering and about the King’s work with a speech therapist to overcome this communication disorder heard in speeches such as this one he delivered in Wembley Stadium.